Sharon Arrol
Impact in
- Clinical Biochemistry top 0.05%
- Paraoxonase enzyme and polymorphisms
- Biochemistry top 0.2%
- Biochemical Acid Research Studies
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Paraoxonase enzyme and polymorphisms 12
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Co-authors
- Michael I. MacknessPaul N. DurringtonCaroline A. AbbottDeepak BhatnagarBharti MacknessP DurringtonWajdi TurkieMike Mackness
- Journals
- Atherosclerosis (15 papers)FEBS Letters (3 papers)Diabetic Medicine (3 papers)Clinical Science (1 paper)Biochemical Journal (1 paper)
- Partner nations
- United KingdomNew ZealandUnited States
In The Last Decade
Sharon Arrol
43 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Clinical Biochemistry 2.9k
- Biochemistry 837
- Pharmacology 1.1k
- Endocrinology, Diabetes and Metabolism 1.0k
- Biochemistry 362
Countries citing papers authored by Sharon Arrol
This map shows the geographic impact of Sharon Arrol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Arrol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Arrol more than expected).
Fields of papers citing papers by Sharon Arrol
This network shows the impact of papers produced by Sharon Arrol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Arrol. The network helps show where Sharon Arrol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sharon Arrol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 52 | |
| 2 | 2007 | 58 | |
| 3 | 2000 | 37 | |
| 4 | 1998 | 233 | |
| 5 | 1997 | 44 | |
| 6 | Hypoxia induces HSP 70 gene expression in human hepatoma (HEP G2) cells. | 1995 | 45 |
| 7 | 1993 | 56 | |
| 8 | Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase Hit paper breakdown → | 1993 | 689 |
| 9 | 1992 | 29 | |
| 10 | 1992 | 80 | |
| 11 | 1992 | 5 | |
| 12 | 1991 | 45 | |
| 13 | 1991 | 25 | |
| 14 | Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein Hit paper breakdown → | 1991 | 822 |
| 15 | 1991 | 21 | |
| 16 | 1991 | 64 | |
| 17 | 1990 | 54 | |
| 18 | 1990 | 58 | |
| 19 | 1990 | 65 | |
| 20 | 1988 | 245 |
About Sharon Arrol
Sharon Arrol is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Biochemistry, Biochemistry and Nephrology, having authored 43 papers that have together received 4.7k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Paraoxonase enzyme and polymorphisms (12 papers), Lipoproteins and Cardiovascular Health (8 papers), Cancer, Lipids, and Metabolism (5 papers), Lipid metabolism and disorders (4 papers), Apelin-related biomedical research (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Clinical Biochemistry (2.9k citations), Biochemistry (837 citations), Pharmacology (1.1k citations), Endocrinology, Diabetes and Metabolism (1.0k citations) and Biochemistry (362 citations). Sharon Arrol has collaborated with scholars based in United Kingdom, New Zealand and United States. Frequent co-authors include Michael I. Mackness, Paul N. Durrington, Caroline A. Abbott, Deepak Bhatnagar, Bharti Mackness, P Durrington, Wajdi Turkie, Mike Mackness, Peter Winocour and M. Ishola. Their work appears in journals such as Atherosclerosis, FEBS Letters, Diabetic Medicine, Clinical Science and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.